Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $17.14 million. The enterprise value is $712,414.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 14.52 million shares outstanding. The number of shares has increased by 6,147.47% in one year.
| Current Share Class | 14.52M |
| Shares Outstanding | 14.52M |
| Shares Change (YoY) | +6,147.47% |
| Shares Change (QoQ) | +39.44% |
| Owned by Insiders (%) | 0.17% |
| Owned by Institutions (%) | 5.74% |
| Float | 14.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.42 |
| P/TBV Ratio | 1.41 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.31, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.31 |
| Quick Ratio | 2.15 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -88.12 |
Financial Efficiency
Return on equity (ROE) is -150.58% and return on invested capital (ROIC) is -61.58%.
| Return on Equity (ROE) | -150.58% |
| Return on Assets (ROA) | -41.03% |
| Return on Invested Capital (ROIC) | -61.58% |
| Return on Capital Employed (ROCE) | -140.51% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.52M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -377,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.62% in the last 52 weeks. The beta is 0.24, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | -18.62% |
| 50-Day Moving Average | 1.51 |
| 200-Day Moving Average | 1.13 |
| Relative Strength Index (RSI) | 38.58 |
| Average Volume (20 Days) | 241,329 |
Short Selling Information
The latest short interest is 378,752, so 2.61% of the outstanding shares have been sold short.
| Short Interest | 378,752 |
| Short Previous Month | 457,642 |
| Short % of Shares Out | 2.61% |
| Short % of Float | 2.61% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.10M |
| Pretax Income | -24.47M |
| Net Income | -24.66M |
| EBITDA | -17.07M |
| EBIT | -17.10M |
| Earnings Per Share (EPS) | -$3.02 |
Full Income Statement Balance Sheet
The company has $17.80 million in cash and $1.38 million in debt, giving a net cash position of $16.43 million or $1.13 per share.
| Cash & Cash Equivalents | 17.80M |
| Total Debt | 1.38M |
| Net Cash | 16.43M |
| Net Cash Per Share | $1.13 |
| Equity (Book Value) | 12.17M |
| Book Value Per Share | 0.83 |
| Working Capital | 11.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$16.82 million and capital expenditures -$298,000, giving a free cash flow of -$17.11 million.
| Operating Cash Flow | -16.82M |
| Capital Expenditures | -298,000 |
| Free Cash Flow | -17.11M |
| FCF Per Share | -$1.18 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6,147.47% |
| Shareholder Yield | -6,147.47% |
| Earnings Yield | -143.87% |
| FCF Yield | -99.86% |
Analyst Forecast
The average price target for ALLR is $9.25, which is 683.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.25 |
| Price Target Difference | 683.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 11, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |